Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients

In Depth Observational Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05423678

Enrollment

500

Registered

2022-06-21

Start date

2024-07-31

Completion date

2026-07-31

Last updated

2024-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ALS, Amyotrophic Lateral Sclerosis

Keywords

als, als clinical trials, als diversity studies, amyotrophic lateral sclerosis

Brief summary

Clinical trial participation has always been substantially skewed toward certain demographic groups. However, there has been little study on whether trial qualities impact participation in either a positive or negative way. The goal of this research is to identify the characteristics that consistently restrict patients' ability to participate in or complete a trial in which they were initially interested. This data will be analyzed via a number of demographic lenses in order to find trends that could benefit future ALS sufferers.

Interventions

None listed

Study design

Observational model

CASE_CROSSOVER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Lives in the United States * Is 18+ years old * Participant has a diagnosis of Amyotrophic Lateral Sclerosis (ALS) * Participant has enrolled in an interventional clinical for ALS (self-reported)

Exclusion criteria

* Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form * No diagnosis of Amyotrophic Lateral Sclerosis (ALS) confirmed

Design outcomes

Primary

Measure	Time frame
Number of patient decides to enroll in clinical trial	3 months
Rate of patients who remain in clinical trial to trial completion	12 months

Contacts

Primary ContactMichael B Gill

https://www.withpower.com/contact-us@withpower.com415-900-4227

Outcome results